Lewis Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Lewis Capital Management's AMGN Position: Q3 2023 in Review
Lewis Capital Management increased its Amgen (AMGN) stake by 6.1% in Q3 2023, buying an estimated $74.9K and bringing the position to 5,201 shares worth $1.4M. The position accounts for 2.18% of the portfolio, ranked #8.
Lewis Capital Management first reported a position in AMGN in Q4 2021 and has held it in 8 quarters since. The position peaked at $1.41M in Q1 2022. 2,502 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.
- Lewis Capital Management held 5,201 shares of Amgen worth $1.4M as of Q3 2023.
- Lewis Capital Management bought 300 Amgen shares in Q3 2023, an estimated $74.9K.
- Amgen made up 2.18% of Lewis Capital Management's portfolio in Q3 2023, its #8 holding.
- Lewis Capital Management first reported a position in Amgen in Q4 2021 and has held it in 8 quarters since.
- Lewis Capital Management's Amgen position peaked at $1.41M in Q1 2022.
- 2,502 funds tracked by Wall St. Rank held Amgen as of Q3 2023.
Based on Lewis Capital Management's 13F filing for Q3 2023, filed 8 Nov 2023.